Evidence map›Paper›PMID 38444524›Full record

ArticleLeukemia research reports2024

Hiroki Hosoi, Shotaro Tabata, Hideki Kosako, Yoshikazu Hori, Tadashi Okamura, Yusuke Yamashita, Kota Fujimoto, Daiki Kajioka, Kentaro Suzuki, Motomi Osato and 2 more

Open access · goldAbstract read
In one paragraph

Article in Leukemia research reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 citations in OpenAlex.

  1. Decoding IGLL5 Mutation-Mediated BCR Signaling: A Novel Mechanism of CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Hiroki HosoiDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
Shotaro TabataDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
Hideki KosakoDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
Yoshikazu HoriDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
Tadashi OkamuraDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
Yusuke YamashitaDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
Kota FujimotoDepartment of Developmental Genetics, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan.
Daiki KajiokaDepartment of Developmental Genetics, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan.
Kentaro SuzukiFaculty of Life and Environmental Sciences, University of Yamanashi, Takeda 4-4-37, Kofu City, Yamanashi, Japan.
Motomi OsatoInternational Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan.
Gen YamadaDepartment of Developmental Genetics, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan.
Takashi SonokiDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
Wakayama Medical University · JPKumamoto University · JPTakeda (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immunoglobulin lambda like polypeptide 5 (igll5)Mature b-cell lymphomaSuper-enhancer, SiRNA

Identifiers

PMID38444524
PMCPMC10912717
OpenAlexW4392028840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.